High Compensation to Non-Executive Directors is a Concern for Tesla Shareholders

    Institutional Shareholder Services, one of the three leading proxy firms, has advised U.S. car giants Tesla Inc. investors and shareholders not to approve the re-election of two Board Directors next month. 

    James Murdoch, son to Media Baron Rupert Murdoch and Kimble Musk, younger brother of  

    CEO Elon Musk is standing for re-election in October.

    According to Bloomberg sources, Institutional Shareholder Services (ISS) on September 24 wrote to clients asking them to vote against directors Kimbal Musk and James Murdoch because of concerns regarding their compensation. ISS is of the view that the two named Executive officers and other non-executive directors are receiving excessive compensation compared to industry standards. 

    The annual shareholder meeting of Tesla Inc. on October 7 this year will be held in its new factory in Austin, Texas. Tesla currently has nine Directors on the board of which Murdoch and Musk, both 48 years, are the two incumbents. Murdoch has been the CEO of 21sst Century Fox during the period 2015 to 2019, whereas Musk is a food entrepreneur who is also a director on the board of SpaceX, owned by Elon Musk.

    Another director, PE investor Antonio Gracias is not standing for re-election, and there will be no replacement for him. This effectively will bring down the total number of directors to eight. As per Bloomberg news, ISS said that the director’s level of compensation was abnormal compared to other peer companies’ directors. It wondered the rationale behind the high magnitude of stock options given without any explanation. 

    “Tesla’s non-executive directors’ compensation is higher compared to what the companies in the GICS sector or the largest U.S. public companies pay to their directors,” ISS observed. 

    According to the ISS report, non-executive directors Hiromichi Mizuno and Robyn Denholm received $9.23 million and $5.76 million, respectively. The outgoing director Antonio Gracias was paid $1.19 million towards compensation. 

    The major component of the compensation to the three directors was stock option grants. They were valued at $9.21 million to Hiromichi Mizuno, $5.63 million to Robyn Denholm, and $1.16 million to Antonio Gracias.


    RELATED ARTICLES

    Fintech trends

    5 Emerging Fintech Trends Banks Can’t Ignore

    The information age has ushered in a speed of change not seen since the Industrial...
    Alstone Textiles share price target 2025

    Alstone Textiles Share Price Target 2025: A Growth Story? 

    If you are looking for high-growth Indian companies to invest your hard-earned money in, then...
    Incredible Rules of Money

    15 Money Rules to Build Wealth Faster

    Most people work hard to earn money, save what they can, and hope to build...
    Financial Security

    Critical Illness Health Insurance: Why You Need It for Financial Security

    Medical emergencies are unpredictable, and the financial strain they bring can be overwhelming. A critical...
    Tips for Managing Risk

    How to Short NVDA Safely: Tips for Managing Risk

    Every stock that goes up must eventually come down (or at least correct). NVIDIA (NVDA)...
    Income Tax Slab Changes

    Income Tax Slab Changes in 2025: How Your Savings Strategy Should Evolve

    The Indian tax system evolves every year, and income tax slab revisions can significantly impact...
    What does the windmill symbolize in the story? Marxism Technology Revolution Capitalism

    What does the windmill symbolize in the story? Marxism Technology Revolution Capitalism

    George Orwell’s Animal Farm evaluates totalitarianism and the history of socialist ideals. What does the...
    How does a hash help secure Blockchain Technology?

    How Does a Hash Help Secure Blockchain Technology?

    Blockchain technology has made many different industries flip a switch to efficiencies with decentralization and...
    blood sugar monitor without finger pricks Amazon

    Blood Sugar Monitor Without Finger Pricks Amazon: Pain-Free Solution

    Managing blood sugar stages is a critical thing of diabetes care, historically requiring frequent finger...
    pradhan mantri kisan samman nidhi news

    Pradhan Mantri Kisan Samman Nidhi News Today!

    The Pradhan Mantri Kisan Samman Nidhi (PM-KISAN) scheme is a government initiative designed to provide...
    which career combines DNA technology and medicine?

    Explore Careers That Combine DNA Technology and Medicine

    Which career combines DNA technology and medicine? That's the question many aspiring professionals find themselves...